A randomized trial of an acceptance-based behavioral intervention for weight loss in people with high internal disinhibition.

Objective: To determine whether an acceptance-based behavioral intervention (ABBI) produces better weight losses than standard behavioral treatment (SBT) among individuals reporting high internal disinhibition.

Methods: Participants were 162 adults with overweight or obesity (mean BMI 37.6 kg/m ) randomly assigned to ABBI or SBT.

Weight loss intervention for individuals with high internal disinhibition: design of the Acceptance Based Behavioral Intervention (ABBI) randomized controlled trial.

Background: Obesity is public health problem associated with significant health risks and healthcare costs. Behavioral weight control programs produce clinically meaningful weight losses, however outcomes have high variability and maintenance continues to be a problem. The current study is an NIH-funded randomized clinical trial testing a novel approach, Acceptance-Based Behavioral Intervention (ABBI), that combines techniques from standard behavioral treatment (SBT) and Acceptance and Commitment Therapy (ACT).

Acceptance and Commitment Therapy for weight control: Model, evidence, and future directions.

Behavioral weight loss programs achieve substantial short-term weight loss; however attrition and poor weight loss maintenance remain significant problems. Recently, Acceptance and Commitment Therapy (ACT) has been used in an attempt to improve long-term outcomes. This conceptual article outlines the standard behavioral and ACT approach to weight control, discusses potential benefits and obstacles to combing approaches, briefly reviews current ACT for weight control outcome research, and highlights significant empirical questions that remain.